Acalabrutinib With Obinutuzumab in Treatment‐Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3‐Year Follow‐Up. (12th June 2019)

Record Type:: Journal Article
Title:: Acalabrutinib With Obinutuzumab in Treatment‐Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3‐Year Follow‐Up. (12th June 2019)
Main Title:: Acalabrutinib With Obinutuzumab in Treatment‐Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia: 3‐Year Follow‐Up
Authors:: Woyach, J.
Rogers, K.A.
Bhat, S.
Blachly, J.
Jianfar, M.
Hamdy, A.
Frigault, M.M.
Izumi, R.
Munugalavadla, V.
Quah, C.S.
Wang, M.H.
Byrd, J.C.
Abstract:
Is Part Of:: Hematological oncology. Volume 37(2019)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 37(2019)Supplement 2
Issue Display:: Volume 37, Issue 2 (2019)
Year:: 2019
Volume:: 37
Issue:: 2
Issue Sort Value:: 2019-0037-0002-0000
Page Start:: 209
Page End:: 210
Publication Date:: 2019-06-12
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.26_2630 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 12428.xml